The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across ...
The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 ...
Jussi Vasama, CEO of Digital Workforce, discusses the Finnish company's partnership with a U.S. health system and its plans to further grow in the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results